| __timestamp | Eli Lilly and Company | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19615600000 | 122045000 |
| Thursday, January 1, 2015 | 19958700000 | 144427000 |
| Friday, January 1, 2016 | 21222100000 | 215003000 |
| Sunday, January 1, 2017 | 22871300000 | 302238000 |
| Monday, January 1, 2018 | 21493300000 | 408897000 |
| Tuesday, January 1, 2019 | 22319500000 | 392755000 |
| Wednesday, January 1, 2020 | 24539800000 | 520397000 |
| Friday, January 1, 2021 | 28318400000 | 579775000 |
| Saturday, January 1, 2022 | 28541400000 | 667238000 |
| Sunday, January 1, 2023 | 34124100000 | 607521000 |
| Monday, January 1, 2024 | 45042700000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, revenue growth is a key indicator of a company's success. From 2014 to 2023, Eli Lilly and Company has demonstrated a robust upward trajectory, with revenue increasing by approximately 74%, from $19.6 billion to $34.1 billion. This growth reflects Eli Lilly's strategic innovations and market expansions. In contrast, Supernus Pharmaceuticals, Inc., while smaller in scale, has shown impressive growth, with revenue surging by over 400% during the same period, from $122 million to $607 million. This remarkable increase underscores Supernus's ability to carve out a niche in the competitive pharmaceutical landscape. The data highlights the contrasting scales and growth strategies of these two companies, offering valuable insights into their market positioning and future potential.
Who Generates More Revenue? Eli Lilly and Company or Alnylam Pharmaceuticals, Inc.
Eli Lilly and Company vs Genmab A/S: Examining Key Revenue Metrics
Revenue Insights: Eli Lilly and Company and Alkermes plc Performance Compared
Eli Lilly and Company or Vericel Corporation: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Eli Lilly and Company vs ImmunityBio, Inc.
Key Insights on Gross Profit: Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.
Breaking Down Revenue Trends: Eli Lilly and Company vs BioCryst Pharmaceuticals, Inc.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Examining Key Revenue Metrics
Who Generates More Revenue? Biogen Inc. or Supernus Pharmaceuticals, Inc.
Ligand Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Revenue Insights: Supernus Pharmaceuticals, Inc. and Dynavax Technologies Corporation Performance Compared
Revenue Insights: Supernus Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. Performance Compared